We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+24.11%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$3.54B
AUM Growth
+$652M
Cap. Flow
+$38.7M
Cap. Flow %
1.09%
Top 10 Hldgs %
88.46%
Holding
56
New
11
Increased
8
Reduced
10
Closed
7

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$440M
2
FUTU icon
Futu Holdings
FUTU
+$327M
3
JD icon
JD.com
JD
+$125M
4
LI icon
Li Auto
LI
+$16M
5
BIDU icon
Baidu
BIDU
+$15.3M

Top Sells

Rank Stock Value
1
ONC
BeOne Medicines Ltd
ONC
+$648M
2
VIPS icon
Vipshop
VIPS
+$124M
3
BABA icon
Alibaba
BABA
+$113M
4
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$31.3M
5
BBIO icon
BridgeBio Pharma
BBIO
+$28.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 48.32%
2 Healthcare 17.53%
3 Financials 12.55%
4 Communication Services 8.66%
5 Real Estate 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAZE
26
Maze Therapeutics
MAZE
$1.5B
$5.04M 0.14%
+457,535
New +$5.51M
NBP
27
NovaBridge Biosciences American Depositary Shares
NBP
$191M
$4.93M 0.14%
5,980,568
– –
TUYA
28
Tuya Inc
TUYA
$1.04B
$4.74M 0.13%
1,564,400
– –
CTNM
29
Contineum Therapeutics
CTNM
$532M
$4.67M 0.13%
669,337
– –
EM
30
DELISTED
Smart Share Global Ltd
EM
$4.42M 0.13%
3,949,700
– –
SOHU
31
Sohu.com
SOHU
$348M
$2.65M 0.08%
201,432
-309,052
-61% -$4.15M
SGMT icon
32
Sagimet Biosciences
SGMT
$433M
$2.36M 0.07%
724,800
– –
MOGU
33
MOGU Inc
MOGU
$17.3M
$1.87M 0.05%
847,510
– –
BEDU
34
DELISTED
Bright Scholar Education Holdings
BEDU
$1.65M 0.05%
988,143
– –
DHR icon
35
Danaher
DHR
$141B
$1.65M 0.05%
8,026
-5,053
-39% -$1.1M
JOYY
36
JOYY Inc
JOYY
$3.72B
$1.43M 0.04%
34,000
+4,000
+13% +$180K
GE icon
37
GE Aerospace
GE
$364B
$1.35M 0.04%
6,757
-3,571
-35% -$703K
MCO icon
38
Moody's
MCO
$84.4B
$1.23M 0.03%
2,637
-1,840
-41% -$887K
MSCI icon
39
MSCI
MSCI
$42.4B
$1.2M 0.03%
2,128
-1,522
-42% -$885K
CYD icon
40
China Yuchai International
CYD
$1.67B
$1.19M 0.03%
+70,000
New +$1.07M
PACB icon
41
Pacific Biosciences
PACB
$432M
$1.08M 0.03%
918,892
– –
WB icon
42
Weibo
WB
$1.98B
$947K 0.03%
+100,000
New +$1.02M
XYF
43
X Financial
XYF
$196M
$720K 0.02%
+50,000
New +$495K
ALGS icon
44
Aligos Therapeutics
ALGS
$25.9M
$629K 0.02%
76,247
– –
ECX icon
45
ECARX Holdings
ECX
$417M
$504K 0.01%
+400,000
New +$855K
MGX icon
46
Metagenomi Therapeutics
MGX
$45.6M
$205K 0.01%
150,699
-627,069
-81% -$1.49M
LSB
47
DELISTED
LakeShore Biopharma
LSB
$182K 0.01%
75,179
– –
UXIN
48
Uxin Ltd
UXIN
$286M
$76.4K ﹤0.01%
19,156
– –
RDGT
49
Ridgetech Inc
RDGT
$845K
$21.2K ﹤0.01%
134
– –
BBIO icon
50
BridgeBio Pharma
BBIO
$16.5B
– –
-1,023,950
Closed -$28.1M
1
2
3

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, HHLR Advisors held 56 positions worth $3.54B, up 23% from $2.89B the previous quarter. Its ten largest holdings account for 88% of the portfolio.

HHLR Advisors's Q1 2025 filing shows 11 new, 8 increased, 10 reduced and 7 closed positions. Its largest new stake was Li Auto: 620,000 shares worth $15.6M. The largest sale was BeOne Medicines Ltd, an estimated $648M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 48% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.

  • HHLR Advisors's largest Q1 2025 buy was Li Auto: 620,000 shares worth $15.6M.
  • HHLR Advisors added most to Pinduoduo in Q1 2025, an estimated $440M increase.
  • HHLR Advisors's biggest Q1 2025 reduction was BeOne Medicines Ltd, cutting an estimated $648M.
  • HHLR Advisors fully exited Kiniksa Pharmaceuticals in Q1 2025, selling an estimated $31.3M.
  • HHLR Advisors's ten largest holdings make up 88% of its $3.54B portfolio in Q1 2025.
  • HHLR Advisors opened 11 new positions and closed 7 in Q1 2025.
  • HHLR Advisors's portfolio value rose 23% quarter-over-quarter to $3.54B.

Based on HHLR Advisors's 13F filing for Q1 2025, filed 15 May 2025.